Journal details
MOLECULAR THERAPY
CELL PRESS · ISSN 1525-0016 · eISSN 1525-0024
SCIEScopusMEDLINEPubMedPMC
Overview
MOLECULAR THERAPY. ISSN 1525-0016 · eISSN 1525-0024. published by CELL PRESS. United States. Biotechnology & Applied Microbiology · Genetics & Heredity · Medicine, Research & Experimental. impact factor 11.4 (2025). JCR Q1. CAS Zone 1 TOP. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 250 articles · 2025: 607 articles · 2024: 436 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of MOLECULAR THERAPY?
The impact factor recorded for MOLECULAR THERAPY is 11.4 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of MOLECULAR THERAPY?
MOLECULAR THERAPY is listed in CAS Zone 1 and marked as a TOP journal.
Which databases index MOLECULAR THERAPY?
MOLECULAR THERAPY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.